Physician profile
James Hannah
NPI 1245290535
$8,799.54
in general payments reported to CMS, 2019-2025
32 companies · $6,021 in 2025
The $6,021 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $346 · 2021: $800 · 2022: $612 · 2023: $463 · 2024: $283 · 2025: $6,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Food and Beverage: $1,228 · Travel and Lodging: $1,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Food and Beverage | $1,228.12 |
| Travel and Lodging | $1,038.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,573.62 | 2024-2025 | |
| Abbvie INC. | $1,043.93 | 2019-2023 | |
| Exeltis, USA INC. | $302.57 | 2021-2025 | Slynd |
| Sumitomo Pharma America, INC. | $233.15 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $177.28 | 2023-2025 | |
| Organon LLC | $164.82 | 2022-2025 | Nexplanon, Jada System |
| Pfizer INC. | $148.06 | 2020-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $141.09 | 2019-2025 | |
| Millicent US INC | $118.52 | 2025 | Femlyv, Intrarosa |
| Biogen, INC. | $113.14 | 2024-2025 | Zurzuvae |
| Gynesonics, INC. | $93.89 | 2021 | |
| Merck Sharp & Dohme LLC | $67.47 | 2019-2022 | |
| Hologic Sales and Service, LLC | $66.58 | 2020-2022 | |
| Myovant Sciences INC. | $62.95 | 2021-2022 | |
| Medtronic, INC. | $61.43 | 2023 | Ligasure, V-Loc 180 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $53.32 | 2022-2024 | Echelon; Endopath |
| Mylan Pharmaceuticals INC. | $49.55 | 2020-2021 | |
| Evofem Biosciences, INC. | $47.58 | 2021 | |
| Therapeuticsmd, INC. | $41.18 | 2019-2022 | |
| Minerva Surgical, INC | $35.37 | 2023 | |
| Boston Scientific Corporation | $26.35 | 2024 | Advantage System |
| Allergan, INC. | $26.02 | 2019 | |
| Baxter Healthcare | $22.89 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $16.17 | 2021 | |
| Exact Sciences Corporation | $15.88 | 2024 | Cologuard Collection Kit |
| Bard Access Systems, INC. | $15.86 | 2019 | |
| Horizon Therapeutics Plc | $15.65 | 2020 | |
| Lilly USA, LLC | $14.95 | 2021 | |
| Currax Pharmaceuticals LLC | $13.85 | 2021 | |
| Lupin INC. | $13.54 | 2020 | |
| Channel Medsystems, INC. | $11.53 | 2024 | |
| Sage Therapeutics, LLC | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hannah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.